FilingReader Intelligence
Jiuzhou Pharmaceutical announces RMB 176m dividend and share buyback
August 5, 2025 at 08:30 AM UTC•By FilingReader AI
Zhejiang Jiuzhou Pharmaceutical announced a 2025 half-year cash dividend of RMB 2.00 per 10 shares, totaling RMB 176 million.
Combined with RMB 102 million in share repurchases, the distribution represents 52.93% of half-year net profit. The company cancelled 5.79 million repurchased shares, reducing its share capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Zhejiang Jiuzhou Pharmaceutical Company Limited 2025 semi-annual reportAugust 5, 2025 at 08:00 AM UTC
Huatai United Securities Co., Ltd.'s verification opinion on Zhejiang Jiuzhou Pharmaceutical Co., Ltd. using part of the raised funds to increase capital in the implementation entity of the investment projects and implement the investment projects.August 5, 2025 at 08:00 AM UTC
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.'s special report on the deposit and use of raised funds for the first half of 2025August 5, 2025 at 08:00 AM UTC
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.'s semi-annual evaluation report on the 2025 "improving quality and efficiency, enhancing shareholder returns" action planAugust 5, 2025 at 08:00 AM UTC
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. announcement on using part of the raised funds to increase capital to the implementing entity of the fund-raising investment projects for the implementation of the fund-raising investment projectsAugust 5, 2025 at 08:00 AM UTC
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2025 semi-annual report summaryAugust 5, 2025 at 08:00 AM UTC
SSE:603456•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Zhejiang Jiuzhou Pharmaceutical publishes news
Free account required • Unsubscribe anytime